Burlington, Vt and Lake Champlain at dusk

2023 External Advisory Board

NameTitle
Chair 
Roy Jensen, MDProfessor, Pathology and Laboratory Medicine
Professor, Cancer Biology
Director, The University of Kansas Cancer Center
William R. Jewell, M.D. Distinguished Kansas Masonic Professor of Cancer Research and Director, Kansas Masonic Cancer Research Institute, University of Kansas Medical Center
Programs and Shared Resources 
Stanton Gerson, MDDean, School of Medicine
Sr. Vice President for Medical Affairs
(Immediate past) Acting Director, Case Comprehensive Cancer Center
Director, National Center for Regenerative Medicine
Professor, Department of  Medicine
Professor, Department of Environmental Health Sciences
Member, Immune Oncology Program, Case Comprehensive Cancer Center
Steven D. Leach, MDPreston T. and Virginia R. Kelsey Professr
Director, Dartmouth Cancer Center
Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer
Martha Mims, MD, PhDProfessor, Medicine
Chief, Hematology and Oncology
Associate Director of Clinical Research
Dan L Duncan Comprehensive Cancer Center
Dan  L Duncan Professorship, Baylor College of Medicine
Kathi Mooney, RN, PhDDistinguished Professor, College of Nursing
Co-Leader Cancer Control and Population Sciences, Huntsman Cancer Institute
University of Utah
Joe W. Ramos, PhD, MPH
Director, CEO, Louisiana Cancer Research Center
Matthew D. Ringel, MDProfessor and Chair, Department of Molecular Medicine and Therapeutics
Ralph W. Kurtz Chair
Co-Leader Cancer Biology Program
Co-Director Center for Cancer Engineering
Deputy Director, Center for Clinical and Translational Sciences
The Ohio State University Wexner Medical Center & OSU Comprehensive Cancer Center
Susan  T. Vadaparampil, PhD, MPH
Associate Center Director for Community Outreach, Engagement & Equity
Professor, Department of Health Outcomes and Behavior
Director, Behavioral Oncology T32 Postdoctoral Training Program
Moffitt Cancer Center
Administration 
Melissa Fitzmaurice Neligan, MPH, CRAChief Administrative Officer
UCLA Jonsson Comprehensive Cancer Center
Vermont E3 Participants 
Emily Hallgren, PhDAssistant Professor
University of Arkansas for Medical Sciences - Northwest
Tianxiang "Sean" Hu, PhDAssistant Professor
Georgia Cancer Center

 

 

 

 

Diego Adrianzen Herrera, MD Appointed Associate Director of Diversity, Equity, and Inclusion

October 19, 2023 by Kate Strotmeyer

Diego Adrianzen Herrera, MD, Assistant Professor, Medicine-Hematology Oncology

Diego Adrianzen Herrera, M.D., assistant professor of medicine, has been appointed to serve as associate director of diversity, equity, and inclusion for the University of Vermont Cancer Center (UVMCC).  

As associate director, Adrianzen Herrera will help to oversee the Cancer Center’s plan to enhance diversity. He will join the UVMCC senior leadership team and will coordinate programs that advance a culture of inclusion across the four pillars of the cancer center: research, education, community outreach, and clinical care.

Adrianzen Herrera is from Peru and received his Doctor of Medicine and Surgery at Alberto Hurtado School of Medicine at Cayetano Heredia University in Lima, Peru. He did his post-doctoral training as a hematology & medical oncology fellow at the Albert Einstein College of Medicine in New York and an internal medicine residency at the Ichan School of Medicine at Mount Sinai Hospital in New York.

He currently serves on the Diversity, Equity and Inclusion Programs Committee for the American Society of Hematology (ASH) and was a participant in the 2023 ASH Health Equity Collective Roundtable. In 2022, he was named a Diversity, Equity and Inclusion Champion at the annual ASH meeting. Dr. Adrianzen Herrera’s research focuses on health outcomes and translational epidemiology in hematologic malignancies.